Excessive blood pressure reduction may cause dizziness, fatigue, or lightheadednesssigns your antihypertensive medication dose has become excessive
But one item tanks an otherwise solid score: Media endorsement logos are displayed on the site with no links, and the accompanying quotes appear to reference GLP-1 medications in general, not Willow specifically
However, from a regulatory standpoint, BPC-157 is not FDA-approved for human use and is currently prohibited by the World Anti-Doping Agency (WADA)
Finally, different weight loss medications raised concerns about suicidality in the past, including phentermine/topiramate, bupropion/naltrexone, and especially rimonabant, an inverse agonist for the cannabinoid receptor CB1, which was worldwide withdrawn for increased risk of suicidality.SGLT2 inhibitors for depression are a relatively new topic